Validose
Validose’s technology platform is a smart, intranasal medical device that uses biometric analysis to limit and control the dosage of controlled substances, which have the ability to treat a wide variety of medical conditions but may have a high potential for addiction and abuse.
Validose’s technology platform is a smart, intranasal medical device that uses biometric analysis to limit and control the dosage of controlled substances, which have the ability to treat a wide variety of medical conditions but may have a high potential for addiction and abuse. The platform aims to reduce prescription drug abuse through present and future risk management solutions that are integrated into various drug delivery product lines.
The company was founded in 2017 on the principle of solving drug delivery personalisation and adherence to high-risk, high-value and long-term therapies without introducing new risks of addiction.
